Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AddiVance is a stimulant-free, bio-optimized dietary supplement formulated to support cognitive function, attention, and emotional regulation in hyperactive individuals, including children and adults who experience lack of focus, difficulty concentrating, and impulsive behavior.[5][7] Developed by Medella Springs Healthcare, the product combines specific ratios of phosphatidylserine, iron, magnesium, zinc, niacin, vitamin C, vitamin B6, folic acid, vitamin D, fish oil providing omega-3 fatty acids such as EPA and DHA, and turmeric rhizome extract to address nutritional imbalances that may affect brain structure, function, energy production, sleep, and mood.[5] AddiVance is positioned as a clinically validated, drug-free adjunct to lifestyle and dietary modifications, manufactured in cGMP, FDA-registered facilities in the United States, and marketed for brain support, improved cognitive performance, and calmer, more centered behavior.[5][6][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AddiVance.